序号 |
标题 |
次数 |
作者 |
发布时间 |
86626 |
CAS:437608-50-9 Lutathera |
116 |
zyl |
2024-11-22 |
86627 |
Ga-DOTA-WVP Ga-DOTA偶联的WVP肽 双功能螯合剂DOTA修饰WVP肽 |
132 |
zcy |
2024-11-22 |
86628 |
CAS:2057438-24-9 Dotatate tfa |
122 |
zyl |
2024-11-22 |
86629 |
DOTA-tris(TBE)-amido-dPEG24-TFP ester |
99 |
kx |
2024-11-22 |
86630 |
N-(4-乙炔基苯甲酰基)-L-环己基甘氨酸乙酯(PAA-Chg) |
104 |
WYQ |
2024-11-22 |
86631 |
DOTA-iRGD peptide ;DOTA偶联iRGD peptide |
106 |
wyh |
2024-11-22 |
86632 |
CAS:306776-79-4 DOTAGA-tetra (t-Bu ester) |
89 |
zyl |
2024-11-22 |
86633 |
N-丙基-2-炔基邻苯二甲酰亚胺,N-Propyl-2-ethynylphthalimide |
124 |
WYQ |
2024-11-22 |
86634 |
3-羟基-4-((三甲基甲硅烷基)乙炔基)苯甲酸甲酯 |
113 |
WYQ |
2024-11-22 |
86635 |
4-苯乙炔基-4'-二甲氨基查尔酮 |
104 |
WYQ |
2024-11-22 |
86636 |
DOTA-RGD的结构特点 |
98 |
wyh |
2024-11-22 |
86637 |
CAS:872469-60-8 大环化合物 |
98 |
zyl |
2024-11-22 |
86638 |
CAS:1006711-90-5,Maleimide-DOTA,DOTA-马来酰亚胺 |
105 |
kx |
2024-11-22 |
86639 |
1-芳乙炔基-3-芳甲酰基中氮茚,1-Aryl Ethynyl-3-Arylcarbonylindole |
118 |
WYQ |
2024-11-22 |
86640 |
3-羟基-4-((三甲基甲硅烷基)乙炔基)苯甲酸甲酯 |
113 |
WYQ |
2024-11-22 |
86641 |
CAS:157599-02-5 1,4,7,10-四(氨基羰甲基)-1,4,7,10-四氮杂环十二烷 |
112 |
zyl |
2024-11-22 |
86642 |
DOTA-peptides DOTA-多肽 |
91 |
zcy |
2024-11-22 |
86643 |
丁炔基磷杂环戊烷(BYP) |
166 |
WYQ |
2024-11-22 |
86644 |
DOTA-pVEC; DOTA偶联细胞穿膜肽pVEC |
114 |
wyh |
2024-11-22 |
86645 |
2,5-双{β-[p-(6-羟基己氧基)苯基]乙炔基}嘧啶 |
109 |
WYQ |
2024-11-22 |
86646 |
DOTA-DBCO |
83 |
kx |
2024-11-22 |
86647 |
CAS:913542-71-9 DOTA di(tBu)ester |
92 |
zyl |
2024-11-22 |
86648 |
2-(4-羟基-1-丁炔基)苯腈 |
95 |
WYQ |
2024-11-22 |
86649 |
苯乙炔基硅氧硼烷(PESB) |
180 |
WYQ |
2024-11-22 |
86650 |
DOTA-YTA2 ; DOTA偶联细胞穿膜肽YTA2 |
98 |
wyh |
2024-11-22 |
86651 |
DOPE-PEG-DOTA 磷脂-聚乙二醇-大环配体 |
115 |
zyl |
2024-11-22 |
86652 |
N-[4-[1-(2,4-二氨基-6-蝶啶)甲基-3-丁炔基]苯甲酰]-L-谷氨酸烷基酯 |
153 |
WYQ |
2024-11-22 |
86653 |
DOTA-tris(TBE)-amido-dPEG4-TFP ester |
113 |
kx |
2024-11-22 |
86654 |
1,3,5-三[3-(三甲基硅乙炔基)-5-(三异丙基硅乙炔基)苯基乙炔基]苯(B2) |
109 |
WYQ |
2024-11-22 |
86655 |
CAS:177943-88-3 DOTATATE |
110 |
zyl |
2024-11-22 |
86656 |
NOTA-3P-TATE-RGD |
100 |
wyh |
2024-11-22 |
86657 |
1,3,5-三[3-(3-甲基-3-羟基-1-丁炔基)-5-(三异丙基硅乙炔基)苯基乙炔基]苯(B1) |
116 |
WYQ |
2024-11-22 |
86658 |
邻-(3,3-二甲基-1-丁炔基)苯胺 |
92 |
WYQ |
2024-11-22 |
86659 |
p-NH2-Bn-DOTA-tetra(t-Bu ester)的应用领域 |
157 |
kx |
2024-11-22 |
86660 |
8-溴-7-(2-丁炔基)-3,7-二氢-3-甲基-1H-嘌呤-2,6-二酮 |
103 |
WYQ |
2024-11-22 |
86661 |
Tm-Maleimido-DOTA |
121 |
zyl |
2024-11-22 |
86662 |
S,S'-1,4-亚(2-丁炔基)双-L-半胱氨酸(BYDC) |
383 |
WYQ |
2024-11-22 |
86663 |
8-溴-7-(2-丁炔基)-3-甲基黄嘌呤 |
114 |
WYQ |
2024-11-22 |
86664 |
四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
73 |
zyl |
2024-11-22 |
86665 |
DOTA-Lanreotide |
110 |
kx |
2024-11-22 |
86666 |
DOTA-Leu-Gly-Glu-Tyr-Gly-Phe-Gln-Asn-Ala-Leu-Ile-V |
111 |
wyh |
2024-11-22 |
86667 |
cas:2125661-93-8 DO3A-Serotonin DO3A-血清素 |
127 |
zyl |
2024-11-22 |
86668 |
Lu-DOTA-PP-F11N Lu-DOTA偶联迷你胃泌素类似物PP-F11N |
97 |
zcy |
2024-11-22 |
86669 |
CAS号:909024-55-1,DOTA-cyclo(RGDfK) acetate |
101 |
kx |
2024-11-22 |
86670 |
DOTA-(Tyr3)-Octreotate acetate salt |
101 |
zyl |
2024-11-22 |